A. Barrish

506 total citations
15 papers, 226 citations indexed

About

A. Barrish is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Pharmacology. According to data from OpenAlex, A. Barrish has authored 15 papers receiving a total of 226 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Public Health, Environmental and Occupational Health, 2 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in A. Barrish's work include Pregnancy and Medication Impact (3 papers), Pregnancy and preeclampsia studies (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). A. Barrish is often cited by papers focused on Pregnancy and Medication Impact (3 papers), Pregnancy and preeclampsia studies (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). A. Barrish collaborates with scholars based in United States. A. Barrish's co-authors include Timothy Olah, John D. Gilbert, Thomas Greber, Arthur Shedden, Carmen Fernández‐Metzler, Michael R. Dobrinska, Gregory J. Gatto, Thomayant Prueksaritanont, Carl J. Burke and Mark E. Duggan and has published in prestigious journals such as American Journal of Obstetrics and Gynecology, Drug Metabolism and Disposition and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

A. Barrish

15 papers receiving 210 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Barrish United States 9 59 50 40 33 30 15 226
Irving Weliky United States 12 46 0.8× 87 1.7× 40 1.0× 46 1.4× 32 1.1× 21 361
Katarzyna Kosicka Poland 11 35 0.6× 82 1.6× 23 0.6× 36 1.1× 21 0.7× 28 365
N. E. Başcı Türkiye 12 69 1.2× 35 0.7× 85 2.1× 103 3.1× 51 1.7× 25 322
N.G.S. Rao United States 9 58 1.0× 70 1.4× 55 1.4× 80 2.4× 37 1.2× 21 343
Johannes Krämer Germany 10 51 0.9× 59 1.2× 89 2.2× 24 0.7× 28 0.9× 16 350
A Gazzaniga Italy 12 36 0.6× 71 1.4× 14 0.3× 50 1.5× 53 1.8× 23 398
Anna Siemiątkowska Poland 10 28 0.5× 81 1.6× 21 0.5× 33 1.0× 15 0.5× 24 306
C. Peraire Spain 8 47 0.8× 43 0.9× 64 1.6× 37 1.1× 31 1.0× 24 348
Jennifer L. H. Johnson United States 10 68 1.2× 54 1.1× 26 0.7× 19 0.6× 23 0.8× 16 412
Ileana A. Ionita United States 8 31 0.5× 32 0.6× 49 1.2× 21 0.6× 41 1.4× 8 478

Countries citing papers authored by A. Barrish

Since Specialization
Citations

This map shows the geographic impact of A. Barrish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Barrish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Barrish more than expected).

Fields of papers citing papers by A. Barrish

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Barrish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Barrish. The network helps show where A. Barrish may publish in the future.

Co-authorship network of co-authors of A. Barrish

This figure shows the co-authorship network connecting the top 25 collaborators of A. Barrish. A scholar is included among the top collaborators of A. Barrish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Barrish. A. Barrish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Prueksaritanont, Thomayant, Jerome Hochman, Meng Yuan, et al.. (2004). Renal elimination of a novel and potent αvβ3integrin antagonist in animals. Xenobiotica. 34(11-12). 1059–1074. 6 indexed citations
2.
Prueksaritanont, Thomayant, Carmen Fernández‐Metzler, Meng Yuan, et al.. (2004). Disposition of a novel and potent αvβ3antagonist in animals, and extrapolation to man. Xenobiotica. 34(1). 103–115. 7 indexed citations
3.
Brashear, Karen M., C. A. HUNT, Mark E. Duggan, et al.. (2002). Non-peptide αvβ3 antagonists. Part 5: identification of potent RGD mimetics incorporating 2-aryl β-amino acids as aspartic acid replacements. Bioorganic & Medicinal Chemistry Letters. 12(23). 3483–3486. 21 indexed citations
4.
5.
Miller, Richard K., et al.. (1998). Pharmacokinetic studies of enalaprilat in the in vitro perfused human placental lobule system. Teratology. 58(3-4). 76–81. 4 indexed citations
6.
Barrish, A., Timothy Olah, Gregory J. Gatto, Michael R. Dobrinska, & John D. Gilbert. (1996). The Use of Stable Isotope Labeling and Liquid Chromatography/Tandem Mass Spectrometry Techniques to Study the Pharmacokinetics and Bioavailability of the Antimigraine Drug, MK-0462 (Rizatriptan) in Dogs. Rapid Communications in Mass Spectrometry. 10(9). 1033–1037. 20 indexed citations
7.
Ducsay, Charles A., et al.. (1996). Pharmacokinetic and fetal cardiovascular effects of enalaprilat administration to maternal rhesus macaques. American Journal of Obstetrics and Gynecology. 175(1). 50–55. 8 indexed citations
8.
Wong, B K, et al.. (1996). Nonlinear dorzolamide pharmacokinetics in rats: concentration-dependent erythrocyte distribution and drug-metabolite displacement interaction.. Drug Metabolism and Disposition. 24(6). 659–663. 9 indexed citations
9.
Barrish, A., Timothy Olah, Gregory J. Gatto, Michael R. Dobrinska, & John D. Gilbert. (1996). The Use of Stable Isotope Labeling and Liquid Chromatography/Tandem Mass Spectrometry Techniques to Study the Pharmacokinetics and Bioavailability of the Antimigraine Drug, MK-0462 (Rizatriptan) in Dogs. Rapid Communications in Mass Spectrometry. 10(9). 1033–1037. 2 indexed citations
10.
Gilbert, John D., Thomas Greber, Joan D. Ellis, et al.. (1995). The development and cross-validation of methods based on radioimmunoassay and LC/MS-MS for the quantification of the Class III antiarrhythmic agent, MK-0499, in human plasma and urine. Journal of Pharmaceutical and Biomedical Analysis. 13(8). 937–950. 16 indexed citations
11.
12.
Hand, Elizabeth, M Hichens, Timothy Olah, et al.. (1993). Determination of MK-852, a new fibrinogen receptor antagonist, in plasma and urine by radioimmunoassay. Journal of Pharmaceutical and Biomedical Analysis. 11(6). 427–434. 8 indexed citations
13.
Olah, Timothy, John D. Gilbert, & A. Barrish. (1993). Determination of the β-adrenergic blocker timolol in plasma by liquid chromatography—atmospheric pressure chemical ionization mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 11(2). 157–163. 25 indexed citations
14.
Gilbert, John D., Timothy Olah, A. Barrish, & Thomas Greber. (1992). Determination of L-654,066, a new 5α-reductase inhibitor in plasma by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry. Journal of Mass Spectrometry. 21(7). 341–346. 46 indexed citations
15.
Barrish, A., et al.. (1991). Comment on Huttunen K, Grönhagen-Riska C and Fyhrquist F, 1989. Enalapril treatment of a nursing mother with slightly impaired renal function. Clin Nephrol 31: 278.. PubMed. 35(5). 234–234. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Irving Weliky Breakdown of academic impact, for papers by Katarzyna Kosicka Breakdown of academic impact, for papers by N. E. Başcı Breakdown of academic impact, for papers by N.G.S. Rao Breakdown of academic impact, for papers by Johannes Krämer Breakdown of academic impact, for papers by A Gazzaniga Breakdown of academic impact, for papers by Anna Siemiątkowska Breakdown of academic impact, for papers by C. Peraire Breakdown of academic impact, for papers by Jennifer L. H. Johnson Breakdown of academic impact, for papers by Ileana A. Ionita
Rankless by CCL
2026